Arteris director Joachim Kunkel granted 633 shares

Q: How many shares were awarded to AIP director Joachim Kunkel?

The award was for 633 shares of fully vested restricted stock on October 5, 2026. It was based on an average trading price of $22.69 for Arteris common stock from August 24, 2026 through October 5, 2026.

The award represented director retainer fees elected in shares instead of cash, with receipt deferred.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Arteris, Inc. director Joachim Kunkel was granted 633 shares of fully vested restricted stock on October 5, 2026; 75,328 shares were reported as directly held afterward. The award represented retainer fees he elected to receive in shares instead of cash and was based on an average trading price of $22.69 for Arteris common stock from August 24, 2026 through October 5, 2026. He elected to defer receipt of the shares.

Insider Trade Summary

Grant/Award: 633 shares

Grant/Award 1 txn

Insider Kunkel Joachim

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^{F1, F2}	633	$0.00	$0.00

Holdings After Transaction: Common Stock — 75,328 shares (Direct)

Footnotes (2)

F1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69.
F2. The Reporting Person elected to defer the receipt of shares.

Key Figures

Restricted stock awarded: 633 shares Average trading price: $22.69 Direct shares following award: 75,328 shares

3 metrics

Restricted stock awarded 633 shares Granted October 5, 2026

Average trading price $22.69 Arteris common stock, August 24, 2026 through October 5, 2026

Direct shares following award 75,328 shares Reported after the October 5, 2026 award

Key Terms

fully vested restricted stock, retainer fees, average trading price

3 terms

fully vested restricted stock financial

"Fully vested restricted stock"

retainer fees financial

"retainer fees that the Reporting Person elected to receive"

average trading price financial

"based on the average trading price of Arteris, Inc. common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares were awarded to AIP director Joachim Kunkel?

The award was for 633 shares of fully vested restricted stock on October 5, 2026. It was based on an average trading price of $22.69 for Arteris common stock from August 24, 2026 through October 5, 2026.

Why did AIP director Joachim Kunkel receive restricted stock?

The award represented retainer fees that Joachim Kunkel elected to receive in Arteris common stock instead of cash. He elected to defer receipt of the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/06/2026 - 04:19 PM Accepted by SEC EDGAR 10/06/2026 - 04:19 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Joachim

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/05/2026		A		633⁽¹⁾⁽²⁾	A	$0.00	75,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. This grant of restricted stock was made on Oct 5, 2026, based on the average trading price of Arteris, Inc. common stock for the period from August 24, 2026 through October 5, 2026, which was $22.69.

2. The Reporting Person elected to defer the receipt of shares.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Kunkel Joachim	10/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR